Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Revenue: 2019-2025

Historic Revenue for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $1.4 million.

  • CureVac N.V's Revenue fell 90.93% to $1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $560.3 million, marking a year-over-year increase of 686.36%. This contributed to the annual value of $571.9 million for FY2024, which is 888.74% up from last year.
  • As of Q2 2025, CureVac N.V's Revenue stood at $1.4 million, which was up 50.03% from $939,333 recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Revenue peaked at $542.4 million during Q3 2024, and registered a low of $939,333 during Q1 2025.
  • Its 3-year average for Revenue is $64.7 million, with a median of $14.5 million in 2024.
  • As far as peak fluctuations go, CureVac N.V's Revenue soared by 572,956.80% in 2021, and later slumped by 93.01% in 2025.
  • Over the past 5 years, CureVac N.V's Revenue (Quarterly) stood at $47.1 million in 2021, then crashed by 74.67% to $11.9 million in 2022, then soared by 103.71% to $24.3 million in 2023, then slumped by 36.28% to $15.5 million in 2024, then slumped by 90.93% to $1.4 million in 2025.
  • Its Revenue was $1.4 million in Q2 2025, compared to $939,333 in Q1 2025 and $15.5 million in Q4 2024.